BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1424 related articles for article (PubMed ID: 26002293)

  • 1. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis.
    Gómez-Puerta JA; Feldman CH; Alarcón GS; Guan H; Winkelmayer WC; Costenbader KH
    Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1453-62. PubMed ID: 25624071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences and income disparities are associated with poor outcomes in kidney transplant recipients with lupus nephritis.
    Nee R; Jindal RM; Little D; Ramsey-Goldman R; Agodoa L; Hurst FP; Abbott KC
    Transplantation; 2013 Jun; 95(12):1471-8. PubMed ID: 23680929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.
    Feldman CH; Hiraki LT; Liu J; Fischer MA; Solomon DH; Alarcón GS; Winkelmayer WC; Costenbader KH
    Arthritis Rheum; 2013 Mar; 65(3):753-63. PubMed ID: 23203603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.
    Devlin A; Waikar SS; Solomon DH; Lu B; Shaykevich T; Alarcón GS; Winkelmayer WC; Costenbader KH
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1642-53. PubMed ID: 22058067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
    Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
    Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction.
    Newsome BB; McClellan WM; Allison JJ; Eggers PW; Chen SC; Collins AJ; Kiefe CI; Coffey CS; Warnock DG
    Am J Kidney Dis; 2008 Aug; 52(2):251-61. PubMed ID: 18468746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.
    Gómez-Puerta JA; Barbhaiya M; Guan H; Feldman CH; Alarcón GS; Costenbader KH
    Arthritis Rheumatol; 2015 Mar; 67(3):752-60. PubMed ID: 25590668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
    Hiraki LT; Lu B; Alexander SR; Shaykevich T; Alarcón GS; Solomon DH; Winkelmayer WC; Costenbader KH
    Arthritis Rheum; 2011 Jul; 63(7):1988-97. PubMed ID: 21445963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences.
    Bleyer AJ; Tell GS; Evans GW; Ettinger WH; Burkart JM
    Am J Kidney Dis; 1996 Jul; 28(1):72-81. PubMed ID: 8712225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Percutaneous Coronary Intervention Among Black and White Patients With End-Stage Renal Disease in the United States.
    Nee R; Yan G; Yuan CM; Agodoa LY; Norris KC
    J Am Heart Assoc; 2019 Aug; 8(15):e012101. PubMed ID: 31331221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
    Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH
    Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Race and Poverty With Mortality Among Nursing Home Residents on Maintenance Dialysis.
    Nee R; Thurlow JS; Norris KC; Yuan C; Watson MA; Agodoa LY; Abbott KC
    J Am Med Dir Assoc; 2019 Jul; 20(7):904-910. PubMed ID: 30929962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Center-level factors and racial disparities in living donor kidney transplantation.
    Hall EC; James NT; Garonzik Wang JM; Berger JC; Montgomery RA; Dagher NN; Desai NM; Segev DL
    Am J Kidney Dis; 2012 Jun; 59(6):849-57. PubMed ID: 22370021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-Cause and Cause-Specific Mortality Trends of End-Stage Renal Disease Due to Lupus Nephritis From 1995 to 2014.
    Jorge A; Wallace ZS; Zhang Y; Lu N; Costenbader KH; Choi HK
    Arthritis Rheumatol; 2019 Mar; 71(3):403-410. PubMed ID: 30225916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry.
    Plantinga L; Lim SS; Patzer R; McClellan W; Kramer M; Klein M; Pastan S; Gordon C; Helmick C; Drenkard C
    Arthritis Care Res (Hoboken); 2016 Mar; 68(3):357-65. PubMed ID: 26239749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race, Ethnicity, and End-of-Life Care in Dialysis Patients in the United States.
    Foley RN; Sexton DJ; Drawz P; Ishani A; Reule S
    J Am Soc Nephrol; 2018 Sep; 29(9):2387-2399. PubMed ID: 30093455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.
    Plantinga LC; Patzer RE; Drenkard C; Pastan SO; Cobb J; McClellan W; Lim SS
    BMC Nephrol; 2015 Mar; 16():39. PubMed ID: 25884409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of death in pediatric and adult patients with ESRD secondary to lupus.
    Sule S; Fivush B; Neu A; Furth S
    Pediatr Nephrol; 2011 Jan; 26(1):93-8. PubMed ID: 20890767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.